Home/Filings/4/A/0001127602-25-013864
4/A//SEC Filing

Joyner J. David 4/A

Accession 0001127602-25-013864

CIK 0000064803other

Filed

May 8, 8:00 PM ET

Accepted

May 9, 4:32 PM ET

Size

5.3 KB

Accession

0001127602-25-013864

Insider Transaction Report

Form 4/AAmended
Period: 2025-04-01
Joyner J. David
EVP, Sales & Account Services
Transactions
  • Award

    Common Stock (RSUs)

    2025-04-01+53,32482,515 total
Footnotes (1)
  • [F1]The purpose of this amendment is to correct the number and type of derivative securities granted to the reporting person on April 1, 2025, which was originally reported on a Form 4 filed on April 3, 2025 (the "Initial Form 4"). The Initial Form 4 incorrectly reported that the reporting person was granted stock options. As reported in this amendment, the reporting person was granted 53,324 restricted stock units ("RSUs"), awarded pursuant to Issuer's 2017 Incentive Compensation Plan, and not 226,138 stock options, as reported in the Initial Form 4. Restrictions on the RSUs lapse in four equal annual installments, commencing 4/1/2026.

Issuer

CVS HEALTH Corp

CIK 0000064803

Entity typeother

Related Parties

1
  • filerCIK 0001515598

Filing Metadata

Form type
4/A
Filed
May 8, 8:00 PM ET
Accepted
May 9, 4:32 PM ET
Size
5.3 KB